Listen Get

Where Am I Wrong?

Author
Affiliation

Mike P. Sinn

International Campaign to End War and Disease

Keywords

argument, 1% treaty, shareholder lawsuit, military contractors, sequence of facts

The whole idea is: how are we supposed to get this into people’s brains so they understand why they should do this? And what is the correct sequence of facts to get it into their brains?

It takes about 100 nuclear weapons to cause a nuclear winter and destroy the food chain and civilization. We have 12,241 nuclear weapons. That is enough for 122 apocalypses. If you were to redirect 1% of US military spending, or sacrifice one of our 122 apocalypses worth of capacity, that would be enough to increase the number of clinical trials by 12.3 times.

Currently there are about 6,650 uncured diseases, and we discover about 15 first treatments for new diseases every year. At the current rate it is going to take 443 years to cure all the diseases. 99.7% (95% CI: 99%-100%) of the potential uses for the 9,500 known safe treatments have never been tested. If we were able to sacrifice one apocalypse worth of mass murder capacity, we could increase progress 12.3 times. That could compress the disease eradication timeline from 443 years to 36 years.

One might ask: why don’t we do this? Well, we only have one civilization, and after you destroy it you have 121 apocalypses left over that you cannot really use. So it is kind of a waste of money, unless more civilizations just happen to show up that you have to destroy, which is unlikely.

You might say a 1% improvement in resource allocation is simply impossible, politically. Maybe this current amount of spending is necessary to prevent some sort of invasion. However, in 1939, prior to the United States winning World War II, military spending was 96.7% lower than it is currently, even after adjusting for inflation. So unless there has been significant degradation in the human genome over the last two generations, a 1% reduction should be manageable.

Additionally, following World War II, the United States decreased military spending by 87.6% over a period of two years. So it is obviously physically possible to do this. And that reduction was followed by the greatest growth in human standard of living in human history. Because, instead of blowing up cities that cost billions or trillions of dollars to rebuild, and instead of paying tons of people to stop doing productive, useful things that would improve Earth in order to instead murder lots of people who would otherwise have been doctors and engineers and scientists and teachers and nurses, all of that labor became available again. When you spend your time murdering people, the dead people cannot do productive labor to improve Earth, and the people doing the murdering cannot do productive labor either.

Currently you have about a 1 in 30 million chance of being killed by terrorists, and you have approximately a 100% chance of being killed by a horrible disease. Yet we spend about 604 (95% CI: 453-894) times more on capacity for mass murder than on clinical trials to find cures for the diseases that are likely to kill you. It does not really make a lot of sense to spend 604 (95% CI: 453-894) times more to deal with the threat that is millions of times less likely to kill you and everyone you love.

So why is this the case? You might think it has to do with money. You might think the problem is that there are military contractors who like money, and so, as Dwight D. Eisenhower warned, in order to obtain money they will spend roughly $127 million (95% CI: $100 million-$160 million) a year legally bribing Congress to just shovel ungodly amounts of money into their businesses. This is how the gross civilization-scale misallocation that causes all these deaths actually happens.

One thing I should have mentioned: the point of government, according to the Constitution, is to promote the general welfare, which can be measured in median after-tax inflation-adjusted income or median health-adjusted life expectancy. The health and wealth of the population. Their job, according to the Constitution, is to promote this. We pay them $36.5 trillion a year for this service and it would be nice to receive this service at some point. Instead, since 1900, governments have used $170 trillion that they were given to murder 262 million of their own employers. These murdered humans include hundreds of thousands of doctors and scientists who would have cured diseases, tons of engineers, several million teachers and nurses, and 102 million kids who would have grown up and maybe discovered cures for diseases and made new inventions that improved the lot of humanity.

As a result of this idiotic misallocation and all these wars, the average human is roughly 23.2 times poorer than they would otherwise be if all this money had been spent on eradicating disease and doing something useful for once. Because of compound interest, which Einstein reportedly called the most powerful force in the universe: a new invention makes other new inventions more useful, and so on.

So everybody is radically poorer than they would otherwise be, and sicker, and deader. That $170 trillion would have been enough to fund 37,778 years of clinical trials at the current government clinical trial spending of $4.5 billion (95% CI: $3 billion-$6 billion) a year. If medical progress continues at its current rate, all diseases and aging would be eradicated within 37,778 years of medical research. I project that if that money had been used for prizes to create medical technology (the most efficient way to produce innovations), we likely would have cured the vast majority of diseases by 1950, if we had had this treaty in 1900 and redirected all the mass murder money. We would have cured aging by approximately 1990.

Since we didn’t do this, imagine the government as a corporation that you paid $36.5 trillion to promote the general welfare. Instead it used the money to murder 262 million of its customers and then wasted the rest. As a result of the misallocation, it caused every death from disease since 1950 and every death from aging since 1990. Under standard liability frameworks used against corporations when they misallocate funds and cause harm, every human would be entitled to roughly $10.6 million (95% CI: $3.5 million-$30.3 million) in a class action lawsuit.

In a world without the cost of disease, which is very expensive, all that money could instead be allocated to useful things that actually improve people’s lives, instead of being wasted on diseases that could have been cured and on blowing up cities and murdering people. Our brains cannot even conceive of how good the world and life would be for every living human.

So the question is: why don’t humans just do it? Stop being irrational and properly allocate resources to promote the general welfare, which could result in Earth being unimaginably good for everyone.

The standard response involves concentrated benefits and diffuse costs. If you are a military contractor and you bribe Congress to allocate 604 (95% CI: 453-894) times more to you than to clinical trials trying to cure diseases, the benefits to you are very high. The costs to society, the costs to the average taxpayer who has to pay these taxes to fund 122 apocalypses worth of capacity even though we only need one, and the costs to their health, are all diffuse. So the public does not have sufficient incentive to coordinate and get the government to stop imposing this cost on them. It is easier for a small number of military contractors to coordinate and collectively bribe Congress to keep doing this.

Maybe that explains it somewhat. However, CEOs and board members in the military industrial complex are also humans, and they want to maximize their net worth. The average age of these CEOs and board members is about 60. In less than 20 years, on average, they will be dead, and their net worth will be zero, unless they are buried with all of their money, which their children are unlikely to do.

So if they are trying to maximize their net worth, and their net worth is going to be zero when they are dead, you would think they would be fighting for this 1% reallocation that could eradicate disease 12.3 times faster. Instead, they prevent the loss of 1% of their income by blocking this treaty.

Since the cost of disease imposes such a huge burden on society, and war has so many external costs, even just this 1% reallocation (about $27.2 billion a year) would, through the decreased burden of disease and the resulting productivity and compounding benefits, result in GDP being approximately 4.1x (95% CI: 2.02x-8.62x) the current trajectory after 15 years of implementation. That means everybody’s net worth would be 200 to 300% higher. Say your net worth is $1 million now. The 1% reallocation costs you roughly $10,000. But if the economy is 2-3x bigger, your net worth is now $2-3 million. If you reinvested in biotech as the treaty passed, your net worth would be radically higher still. You would potentially have an extra 10 or 20 years of healthy life, based on the reduced incidence of disease, and a lower likelihood of an apocalypse destroying everything. But the main thing is just the money. The entire economy would be radically richer, and therefore you would be radically richer. The differential is greatly in excess of the 1% that you would be sacrificing.

So it makes no logical sense for a military contractor to prevent this. Why doesn’t it happen? Because this set of facts has never gotten into the brains of these military contractors. If these facts are all true, and they have never gotten into the brains of these military contractors, and you put them into the brains of these military contractors who are rational agents presumably capable of logical thought and interested in maximizing their net worth, then they would reinvest their personal money into biotechnology, and use the money they currently spend lobbying for the 604 (95% CI: 453-894)-to-1 ratio of bombs to curing diseases to instead lobby for redirecting 1% of military spending to pragmatic clinical trials.

So how do you get this information into their brains? You can try to email them, but it is hard to get in contact with them. However, if you are a shareholder of one of these corporations, you can file a lawsuit against them, and it is their obligation to act in the best interests of their shareholders and allocate company resources responsibly for the benefit of their shareholders. By lobbying for this gross misallocation of resources, they are the fundamental cause of their shareholders (and all humans) dying radically sooner, suffering from many more diseases, and being much poorer than they would otherwise be in a world where we just hurried up and eradicated all these diseases instead of making more doomsday machines.

So you would have legal standing to sue them as a shareholder. It is uncertain: there’s maybe a 20% chance of success, and you could potentially sue for a claim of up to roughly $10.6 million (95% CI: $3.5 million-$30.3 million). It is basically free. You have to buy at least one share, about $3,000 worth. You send them a letter, and the board of the company has to review the letter and respond, or you can file a lawsuit for breach of that obligation too.

Let’s say they review the letter. In your letter, you explain everything above. So all of this gets into their brains. Presumably at this point you may be done, and you have triggered a chain reaction that will cause them to absorb this information. If they are rational actors, they will then use their current $127 million (95% CI: $100 million-$160 million) a year of lobbying spending to instead lobby for the redirection of money to eradicate disease.

Alternatively, let’s say they are not rational actors and they decide to fight you in court. You get a bunch of news publicity about this. They spend several million dollars fighting you. This additional legal spending is also a misallocation of company resources, so it can be used as evidence in a derivative case where you sue them again for even more money. The more they waste defending against this, the greater your standing in court.

The alternative you give them is a settlement offer. Your settlement offer is that they proceed to use all of their current lobbying spending on lobbying for the reallocation of 1% of military spending to fund pragmatic clinical trials and eradicate disease. So they have no choice but to use their money to lobby for the passage of this treaty.

Anyone who doesn’t like war and/or disease and has $3,000 can file a lawsuit and force the board to read all this information over and over and over again. Theoretically this could be done in many different nations.

Even if the legal side didn’t work out, it would probably get lots of news coverage. So all these facts would likely eventually end up in the brains of 8 billion people, including presidents and congressmen and senators. At that point, 8 billion people would realize that the current arrangement is not benefiting anyone, literally anyone, in the long term. On net, it is negative infinity for everyone, because everyone’s net worth is going to be zero when they are dead.

Where am I wrong?

Frequently Asked Objections

Objection: The Business Judgment Rule makes the derivative lawsuit a near-loser.

Delaware courts give boards enormous deference on lobbying and strategic decisions. The base-rate success rate on the merits for Caremark-style derivative suits is closer to 1-2%, not 20%. And in a derivative suit the recovery flows to the corporation, not to the filing shareholder, so the “$3,000 in shares → $10 million claim” framing collapses on first contact with a securities lawyer.

Refutation:

OK, let’s say there is only a 1 to 2% chance of success on this lawsuit, and you make a claim for $10 million. So what? The expected value is 1% × $10 million = $100,000. The cost to file the lawsuit is basically the cost of sending a letter. It is possible to get pro bono lawyers to do this. We make a legal template, so you just have to buy $3,000 worth of shares and send in the letter, and we hand you the template. So the expected value is $100,000. It is in the interest of every human who can afford $3,000 worth of shares to file the lawsuit.

And let’s say the recovery belongs to the company. If everybody on Earth tries to buy one share of every military contractor, could humanity do a hostile takeover of the military industrial complex and then in turn vote to distribute this income to the shareholders?

What is the evidence for the 1-2% number anyway? It is a base rate from generic derivative suits where the judge has no personal stake in the outcome. This is not that kind of case. The judge is a human who will die of disease. So is everyone the judge loves. A ruling for the defendant is a ruling that the lobbying continues, that the disease queue stays 443 years long, and that the judge and their family stay on the slow timeline. Standard base rates assume the judge is indifferent to which way the case goes outside the courtroom. Here, they are not. Plausible case-specific estimate: 3-8% on the merits, with much higher probability (30%+) of forcing a publicly visible board response that itself becomes ammunition for the next filing.

Objection: The defense team has institutional reasons to fight even if the math favors the plaintiff.

The CEO, board, and defense counsel are constrained by structures that block them from acting on their personal interest in the treaty passing:

  • Fiduciary duty to current shareholders. The CEO is legally required to maximize value for current shareholders. Pivoting the lobbying budget tanks short-term earnings; current shareholders sue for breach.
  • Lawyer’s role. Defense counsel is professionally obligated to mount zealous advocacy. A lawyer who recommended “help the plaintiff win” would be malpracticing.
  • First-mover disadvantage. If Lockheed pivots alone, Boeing and Raytheon eat their market share.
  • Time horizons. CEOs are evaluated quarterly. The treaty’s GDP-doubling payoff is 15 years out. They get fired at year 2 for tanking the stock.
  • Institutional filtering. The board never reads the underlying math. The general counsel summarizes the demand letter as “fringe theory, recommend motion to dismiss.” Deep thinking is exactly what the institutional pipeline filters out.

Refutation:

You are treating these people as platonic ideals of a CEO and a lawyer who do not care about their own mortality or what happens to their friends and family. They are not platonic ideals. They are humans who are going to suffer and die from diseases, along with everyone they love, on the current trajectory.

On fiduciary duty: the duty is to make shareholders financially better off. If the CEO’s actions cause the shareholders to be much poorer in 20 years and have a net worth of zero because they are dead, then continuing those actions is the breach of duty. Fiduciary duty does not mean “preserve current revenue.” It means “make shareholders better off financially.” The treaty makes shareholders 200-300% better off and keeps them alive. Once the shareholders understand the math (which the public filing of the lawsuit forces), the CEO faces no competing duty. Every shareholder wants the treaty.

On the lawyer: every day they prolong disease eradication, they cause roughly 150 thousand deaths. They are not defending the case as a hobby because adversarial proceedings are fun. They are doing it for money, to provide for their family and improve their life. The lawyer is a human. The lawyer’s family is human. They are also going to suffer and die from horrible diseases on the current trajectory. If the lawyer recognizes that the money they earn fighting this case buys them and their family a shorter, sicker life, the rational play is to refuse the case, mount a deliberately weak defense, or quietly advise their client to settle.

On the rest: every friction you cite (the general counsel filters the letter, the board never reads the math, the first-mover problem prevents coordination, quarterly evaluation cycles) is a failure mode for an uninformed defense team. The mechanism of the lawsuit is precisely to force the information in. You file in multiple jurisdictions, against multiple contractors, with coordinated media coverage. You make the case impossible to route around. You make the first-mover problem moot by filing against everyone simultaneously. The point of the campaign is to dismantle every friction you cite by making the math unavoidable.

The objection assumes deep thinking does not happen. The strategy assumes deep thinking is what we are forcing.

Objection: No court will order a corporation to lobby for a specific treaty.

That is outside the equitable powers of a court reviewing a derivative claim, and it runs into First Amendment compelled-political-speech problems from the Citizens United line of cases.

Refutation:

The judge and the court are made of humans. If the judge and the court think thoroughly about this, their opposition to assisting in this effort is going to result in their own death and the suffering and death of everyone they love from disease. Your assumption is that they value process over the suffering and death of everyone they love. My claim is that the process exists to promote the general welfare, which entails and requires preventing the suffering and death of everyone you have ever loved.

Objection: 12.3x more trials does not equal 12.3x more cures (diminishing returns).

Doubling biomedical research dollars does not double cures. Diminishing returns on research are well documented (Bloom et al., “Are Ideas Getting Harder to Find?”). The 443 → 36 years compression assumes linear scaling, and the cure rate is sublinear in trial count.

Refutation:

You are basing this on a situation where trials are only done on profitable novel molecules. These trials are done on all potentially medicinal molecules, regardless of whether they are profitable, and the cost is about 44.1 times cheaper than traditional trials. Additionally, under this system, it is a decentralized FDA157,158 where all information is published, giving us additional public and shared information about the effectiveness of each intervention on each target. This allows us to better understand human biology and improves our ability to target and select the next intervention. You can aggregate all of this data, rank interventions, and always be trialing the most promising intervention available based on the entire universe of data. Therefore, the number of cures produced per trial should increase over time.

We are not running out of low-hanging fruit. 99.7% (95% CI: 99%-100%) of the potential uses of 9,500 known-safe but generally unpatentable interventions have never been tested. You can’t run out of low-hanging fruit if you haven’t even gone into the orchard.

Objection: GDP doubling does not mean every individual’s net worth doubles.

GDP growth does not accrue evenly. The reader you most need to persuade may hear “the average doubles” as “I get screwed because I am not average.”

Refutation:

I don’t think the average person is going to have this objection.

Objection: “$10 million per human in a class action” sounds fanciful next to the other numbers.

It is technically a defensible counterfactual calculation, but it presents conjectural damages with the same confidence as the existing-disease numbers. That contaminates the solid figures next to it by association.

Refutation:

The damages calculation is not back-of-envelope. See Humanity v. Government for the full liability framework, the per-capita numbers under each pleading theory (lifetime lost income, strict-floor body-count, prosecutor’s gross pleading), and the sources.

Objection: “They are bad at arithmetic, not evil” is the weakest claim in the argument.

Defense CEOs are not bad at arithmetic. They are wealthy enough that the 1% has no material impact on their personal life. The real barriers are inertia (the lobbying budget runs on autopilot), information (they have never been forced to read the math and write down a reason for disagreeing), and coordination (no CEO wants to be the first mover). All three are exactly what the shareholder letter mechanism attacks.

Refutation:

Conceded. Updated in the handout to read: “They are not evil. They are wealthy enough that they don’t need the 1%. They have just never been forced to read the math.”

Objection: Defense contractors will not sit still. The PSLRA precedent matters.

The strategy implicitly assumes a passive defendant. They will not be passive. Expect counterclaims for vexatious litigation designed to deter copycats. Expect legislative immunization: in 1995 Congress passed the Private Securities Litigation Reform Act specifically to neuter shareholder litigation that was inconveniencing corporate America, and defense contractors have more legislative leverage than the 1995 securities-fraud bar did. Expect coordinated PR framing the plaintiffs as cranks. Expect personal pressure on identifiable plaintiffs (financial, professional, social).

Refutation:

The PSLRA passed in 1995 because shareholder fraud suits were perceived as a tax on legitimate business that extracted wealth without producing public benefit. This is the opposite: a suit that produces public benefit by forcing the eradication of disease. Any congressional immunization of defense contractors against shareholder claims of negative-ROI lobbying would have to be voted on by congresspeople who also die of disease. Making that vote in public, on the record, is itself a campaign victory. “Senator X voted to immunize defense contractors from being sued for prolonging disease” is a 30-second campaign ad that wins elections.

Counter-suits for vexatious litigation are also a win. They generate more publicity, more litigation, more documentation in the public record. Every dollar the defense industry spends fighting becomes evidence in the next filing that company resources are being misallocated. Their adversarial response is the campaign’s fuel, not its enemy.

Plaintiff harassment is a real risk. The campaign is designed to be decentralized enough that no single plaintiff is a viable target. The Streisand effect compounds. The worst case for the defense industry is a coordinated media story about defense contractors hiring private investigators to intimidate cancer patients who own one share of stock.

Objection: The lawsuit is not the same problem as the treaty.

Even if every contractor capitulated tomorrow and lobbied for the treaty, you still face: China and Russia have to sign and their domestic political incentives differ from US contractors’. Treaty verification is hard because defense budgets are opaque. US Senate hasn’t ratified a major arms-control treaty since New START in 2010; the institution has lost the capacity regardless of merits. The shareholder mechanism solves the lobbying problem. It does not solve the ratification problem.

Refutation:

The lawsuit is not designed to be the treaty. It is designed to flip the most effective political-influence operation on Earth from blocking the treaty to championing it. The defense lobby is the binding constraint on US military policy. Flip them, and the Senate follows, because senators follow the lobby that funds their campaigns.

China and Russia are easier problems with the US lobby flipped than they are with the US lobby blocking. With the US blocking, no foreign government has any incentive to move. With the US lobbying for the treaty, foreign governments face their own domestic shareholder-style arguments: their own elites also die of disease, and their own economies would also grow.

The treaty does not need 190 governments simultaneously. It needs a critical mass. Once the US, EU, Japan, and a few major signers commit, others follow for trade access, reputational reasons, and the same shareholder-EV math run against their own military contractors. The treaty is structured for cascading adoption.

Verification is a real engineering problem. It is also a solved one: SIPRI, IMF, and World Bank already track military spending to within a few percent. The treaty includes mandatory disclosure with audit rights. Cheating is harder than it looks and the consequence of being caught (losing the trade benefits of being a signatory) is large.

Objection: Compounding model uncertainty makes the joint claim weaker than the chain reads.

Each link is probabilistic: 1% → 12.3x trials, 12.3x trials → ~12.3x cures, more cures → 3-4x GDP at year 15, 3-4x GDP → CEO’s personal net worth doubles. A sophisticated CEO can accept the direction of every link and still rationally disagree about the magnitude. “I agree disease eradication is undervalued; I disagree that my company’s lobbying is the binding constraint, and I disagree that the multiplier is 3-4x rather than 1.1x.” None of those positions are irrational. The lawsuit forces them to engage; it does not force them to agree with the magnitude estimates.

Refutation:

Run the conservative case. Cut every multiplier in the chain by an order of magnitude. Assume 1% reallocation → 2x trials (not 12.3x). Assume 2x trials → 1.5x cures. Assume more cures → 1.5x GDP at year 15 (not 3-4x). You still get an enormous reduction in disease burden, an enormous personal benefit to every human alive, and a treaty that pays for itself many times over its 1% cost. The math is overwhelming even at conservative parameters.

The CEO who says “I disagree about the multiplier” has to specify a multiplier so low that the conclusion flips. There is no honest multiplier that low. The cost of being wrong about the multiplier is “we got fewer cures than hoped.” The cost of being wrong about not doing it is “we continued blowing up cities and prolonging disease for another century.” The downside is asymmetric.

Compounding uncertainty cuts both ways, by the way. It is just as likely that the multiplier is higher than estimated as lower, because we are at 99.7% (95% CI: 99%-100%) untested potential uses for known-safe interventions. The point estimate is the median of the distribution, not the worst case.

Objection: Motivated reasoning beats spreadsheets in the empirical record.

The cognitive science is bad for the strategy. Forty years of “smoking causes cancer” warnings produced slow gradual behavior change, not immediate compliance, even though the math is personal and overwhelming. Cardiovascular non-compliance, climate denial, financial discount-rate failures: humans systematically underweight low-probability catastrophic personal outcomes even when their own life is at stake. The “rational agent who reads the math and updates” is an economist’s model, not a psychologist’s.

Refutation:

Smoking is the wrong reference class because it requires the smoker to change their own behavior, which is hard. The treaty requires no behavior change from the public. It requires a budget line item to be adjusted in 190 spreadsheets. The friction is institutional, not personal.

Even taking smoking on its own terms: US adult smoking declined from 42% in 1965 to 12% in 2023. That is a 71% reduction over 58 years through exactly this kind of multi-channel, multi-decade campaign. If the disease-eradication campaign achieves the smoking trajectory, the treaty passes. Slow and gradual is fine. Disease eradication does not need to happen next year; it needs to happen eventually, and 36 years is an acceptable timeline even with substantial campaign drag.

Also: the people who matter (CEOs, judges, senators) are an unusually rational subset of the population, and they are exposed to spreadsheets professionally. They are more responsive to math than the median smoker is, because their job is to read math. Motivated reasoning is strongest when the cost of changing your mind is high. For a senator, the cost of changing their mind on the treaty (once their constituents are wearing the shirts) is low and the cost of not changing it is career death.

Objection: Organizational capacity for a multi-year coordinated campaign does not exist.

Multi-jurisdiction filings, plaintiff recruitment, legal templates updated for each jurisdiction, ongoing media operations, ratification lobbying, coalition management, all simultaneously, for years. Most movements fizzle in year 2 from logistic exhaustion. The strategy assumes an organizational infrastructure that does not yet exist. Building it is a precondition that the math model treats as free.

Refutation:

Why does this need centralized organizational capacity any greater than the website we already have? The website lets people drag a slider to allocate spending between mass murder capacity and clinical trials and vote yes or no on the 1% treaty159 160. That is the entire required interface for the public.

This is not a corporate campaign. It does not need a corporate campaign’s infrastructure. The strategy is fundamentally distributed: information propagation through shirts and news cycles, plus a one-click action (drag slider, vote, optionally file a lawsuit from an open-source template). Each individual actor is incentivized to spread the message because it is, per unit of money and effort, the best thing any human can do for themselves and their family. The mechanism is the same one that made chain letters reach hundreds of millions of people in the 1930s on a stamp and a trip to the post office, without any centralized organizational capacity.

The policy change itself requires modifying two cells in each of 190 federal budget spreadsheets: the mass-murder-capacity cell and the pragmatic-clinical-trials cell. Altering those numbers ends war and disease. If this combination of facts gets into the brains of the people with control over those cells, and they know that approximately 8 billion people would like them to change the values in those cells, and they understand it would be better for them and their families to change the values in those cells, then they would change the values in those cells.

The main barrier is not organizational capacity. The main barrier is that this combination of facts is not yet in their brains. Every part of the strategy (shirts, website, lawsuit, handout, this document) is a delivery vehicle for putting the facts in their brains. Once the facts are in the brains, the action is two cells.

The residual technical infrastructure is real but lightweight: a website, a parameter system, a legal template, a shirt design, a handout. None of these require a corporate-scale organization. They require a small number of people maintaining open-source-style assets that anyone can use without permission. That infrastructure already exists in nascent form.

The honest residual concern: complex multi-step arguments are harder to spread virally than simple slogans. The strategy depends on the chain (overkill capacity → 1% redirection → trial multiplier → GDP compounding → personal mortality) actually reaching brains in a comprehensible form. The handout, shirts, and slider are attempts to compress the chain. Whether the compression is sharp enough to spread at chain-letter velocity is the empirical question the campaign is testing. But this is not an organizational-capacity problem. It is a communication-design problem, and it is solved by iterating on the handout and the shirts, not by building a corporate org chart.

The Funniest Joke in the Universe, Mathematically

The total funniness of this campaign, measured in laughs prevented from being lost to disease and aging, is approximately 3.51 quadrillion laughs (95% CI: 1.61 quadrillion laughs-5.59 quadrillion laughs). For comparison, the average joke produces 1 laugh. This is the funniest joke in human history by a margin of approximately 3.51 quadrillion to 1.

The chain:

  • The average human laughs 17 times per day.
  • That is 6,205 laughs per healthy life-year.
  • The treaty recovers approximately 565 billion DALYs (disability-adjusted life-years) by compressing the disease eradication queue from 443 years to 36 years.
  • 565 billion recovered healthy life-years × 6,205 laughs per year = 3.51 quadrillion laughs.

The full calculation:

\[ \begin{gathered} L_{shirt} \\ = DALYs_{max} \times L_{year} \\ = 565B \times 6{,}200 \\ = 3510T \end{gathered} \]
where:
\[ \begin{gathered} DALYs_{max} \\ = DALYs_{global,ann} \times Pct_{avoid,DALY} \times T_{accel,max} \\ = 2.88B \times 92.6\% \times 212 \\ = 565B \end{gathered} \]
where:
\[ T_{accel,max} = T_{accel} + T_{lag} = 204 + 8.2 = 212 \]
where:
\[ \begin{gathered} T_{accel} \\ = T_{first,SQ} \times \left(1 - \frac{1}{k_{capacity}}\right) \\ = 222 \times \left(1 - \frac{1}{12.3}\right) \\ = 204 \end{gathered} \]
where:
\[ \begin{gathered} T_{first,SQ} \\ = T_{queue,SQ} \times 0.5 \\ = 443 \times 0.5 \\ = 222 \end{gathered} \]
where:
\[ \begin{gathered} T_{queue,SQ} \\ = \frac{N_{untreated}}{Treatments_{new,ann}} \\ = \frac{6{,}650}{15} \\ = 443 \end{gathered} \]
where:
\[ \begin{gathered} N_{untreated} \\ = N_{rare} \times 0.95 \\ = 7{,}000 \times 0.95 \\ = 6{,}650 \end{gathered} \]
where:
\[ \begin{gathered} k_{capacity} \\ = \frac{N_{fundable,ref}}{Slots_{curr}} \\ = \frac{23.4M}{1.9M} \\ = 12.3 \end{gathered} \]
where:
\[ \begin{gathered} N_{fundable,ref} \\ = \frac{Subsidies_{trial,ref}}{Cost_{pragmatic,pt}} \\ = \frac{\$21.8B}{\$929} \\ = 23.4M \end{gathered} \]
where:
\[ \begin{gathered} Subsidies_{trial,ref} \\ = Funding_{trial,ref} - OPEX_{trial} \\ = \$21.8B - \$40M \\ = \$21.8B \end{gathered} \]
where:
\[ \begin{gathered} OPEX_{trial} \\ = Cost_{platform} + Cost_{staff} + Cost_{infra} \\ + Cost_{regulatory} + Cost_{community} \\ = \$15M + \$10M + \$8M + \$5M + \$2M \\ = \$40M \end{gathered} \]
where:
\[ L_{year} = L_{day} \times 365 = 17 \times 365 = 6{,}200 \]

Every objection above is asking you to weigh some friction (legal precedent, institutional inertia, model uncertainty, organizational capacity) against the funniness of this joke. The friction is measured in millions of dollars and years of effort. The joke is measured in quadrillions of laughs. The math does not require a calculator.